Alert detail

FDA Approval: TAPENTADOL (TAPENTADOL HYDROCHLORIDE) — Type 1 - New Molecular Entity

Policy ID: FDA-NDA022304Specialty: Pain ManagementAdded: 6/24/2026Effective: 2008-11-20federal register
Routine

Full alert analysis requires a subscription

Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.